The Main Line Health (MLH) Human Research Protection Program
administered through the Main Line Health Office of Research Protections
and the Main Line Hospitals Institutional Review Board has received full
accreditation by the Association for Accreditation of Human Subject
Research Protection Programs (AAHRPP). A nonprofit organization, AAHRPP
provides accreditation for organizations that conduct or review human
subject’s research. Organizations that achieve accreditation must
demonstrate that their protections exceed the safeguards required by the
“I want to commend the Main Line Health research community, including
physicians, research staff, Main Line Health patients and their
families, who were all an integral part of this achievement,” says Anne
Marie Hobson, Director, Office of Research Protections, Main Line
Health. “I am proud of our team for their work in attaining this
prestigious recognition, which has been awarded to renowned
universities, academic medical hospitals and research organizations
across the globe.”
To earn AAHRPP accreditation, organizations must demonstrate that they
have built extensive safeguards into every level of their research
operation and that they adhere to high standards for research. In
today’s global, collaborative research enterprise, organizations
increasingly rely on AAHRPP accreditation status to help identify
trusted research partners.
To date, AAHRPP has accredited over 200 organizations in 46 states and
many international sites. In addition, more than 60 percent of U.S.
research-intensive universities and over 65 percent of U.S. medical
schools are either AAHRPP accredited or have begun the accreditation
process. The National Institutes of Health, the world’s largest public
funder of research, has earned accreditation, as has Pfizer, Inc., the
sixth largest industry sponsor of clinical research.
Founded in 1985,Main Line Health is a not-for-profit health system serving portions of Philadelphia and its western suburbs. Main Line Health’s commitment—to deliver advanced medicine to treat and cure disease while also playing an important role in prevention and disease management as well as training physicians and other health care providers—reflects our intent to keep our community and ourselves well ahead. A team of more than 10,000 employees and 2,000 physicians care for patients throughout the Main Line Health system.
At Main Line Health’s core are four of the region’s most respected acute care hospitals—Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital—as well as one of the nation’s recognized facilities for rehabilitative medicine, Bryn Mawr Rehabilitation Hospital.
Main Line Health also includes Mirmont Treatment Center for drug and alcohol recovery; Main Line Health HomeCare & Hospice, which includes skilled home health care, hospice and home infusion services; Main Line Health Centers, primary and specialty care, lab and radiology, and other outpatient services located in Broomall, Collegeville, Concordville, Exton, King of Prussia and Newtown Square; Lankenau Institute for Medical Research, a biomedical research organization; and Main Line HealthCare,one of the region’s largest multispecialty physician networks.
Main Line Health is the recipient of numerous awards for quality care and service, including System Magnet® designation, the nation’s highest distinction for nursing excellence and the Mid-Atlantic Alliance for Performance Excellence (MAAPE) Excellence Award. Main Line Health is committed to creating an environment of diversity, respect and inclusion and has proudly embraced the American Hospital Association’s #123forEquity Pledge to Act to eliminate disparities in care. We are dedicated to advancing patient-centered care, education and research to help our community stay healthy.